Provider
QP33-25 Commercial Pharmacy Benefit Exclusion for Bkemv™, Otulfi™, Pyzchiva®, Selarsdi™ and Ustekinumab-ttwe™
Program effective Date: Apr 09, 2025
Program effective Date: Apr 09, 2025
Program effective Date: Apr 09, 2025
Program effective Date: Apr 09, 2025
Program effective Date: May 01, 2025
Program effective Date: May 01, 2025